vision changes with tirzepatide Semaglutide, Linked to Small Increase in Eye Disorder Risk Potential rare vision complications tied

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are gaining increasing attention as first-line agents for the treatment of diabetes and obesity, and with their potential to improve the muscle mass and function, they provide new ideas for the treatment of sarcopenia

I designed this schematic on BioRender to visualize what I think is happening to my patients

Inphase 3 clinical trials (SURPASS 1-5), the dose-dependent efficacy and safety of tirzepatide were assessed by once-weekly subcutaneous injection (5mg, 10mg, and 15 mg), as monotherapy or combination therapy, in individuals with T2DM

Understanding their differences helps you make an informed choice about your personalized weight loss therapy

Market Trends: Semaglutide API Prices Drop Significantly QYOBO data shows a remarkable 66% price decline for Semaglutide from 2022 to 2023, reaching an average of 568 USD per gram in Q2 2024